| | | | | |
| €12,1321 | +0,00% | €214,47M | €1,21M | |
REFI Chicago Atlantic Real Estate Finance, Inc. Common Stock | €10,0237 | +0,00% | €214,39M | €553,30K | |
GTERA Globa Terra Acquisition Corporation Class A Ordinary Shares | €9,0661 | +0,00% | €214,27M | €8,82K | |
NUS NuSkin Enterprises, Inc. | €4,6385 | +0,00% | €214,11M | €1,94M | |
FHTX Foghorn Therapeutics Inc. Common Stock | €3,7161 | +0,24% | €214,05M | €1,07M | |
FATE Fate Therapeutics, Inc. | €1,8448 | +0,00% | €214,01M | €13,45M | |
| €11,8070 | +0,07% | €213,07M | €220,24K | |
VABK Virginia National Bankshares Corporation Common Stock | €40,6306 | +1,60% | €212,98M | €68,46K | |
SCM STELLUS CAPITAL INVESTMENT CORPORATION | €7,4058 | +0,00% | €212,34M | €167,18K | |
IKT Inhibikase Therapeutics, Inc. Common Stock | €1,6604 | -1,05% | €212,26M | €3,35M | |
ARL American Realty Investors, Inc. | €17,4821 | -7,44% | €211,56M | €122,34K | |
RAAQ Real Asset Acquisition Corp. Class A Ordinary Share | €9,2857 | -0,09% | €211,55M | €200,29K | |
MCGA Yorkville Acquisition Corp. Class A Ordinary Share | €8,9827 | +0,15% | €211,30M | €19,48K | |
DHY Credit Suisse High Yield Credit Fund | €1,5374 | +0,00% | €211,16M | €504,72K | |
SOCA Solarius Capital Acquisition Corp. Class A Ordinary Share | €9,0134 | -0,20% | €211,15M | €1,23K | |
